Nanomedicine: Developing smarter therapeutic and diagnostic modalities

Advanced Drug Delivery Reviews

Volumn 58, Issue 14, 2006, Pages 1456-1459

  Farokhzad, Omid C ^a,b   Langer, Robert ^b,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c Massachusetts Institute of Technology   (United States)

Author keywords

Diagnostic; Nanomedicine; Nanoparticle; Targeted; Therapeutic

Indexed keywords

DIAGNOSIS; DRUG THERAPY; MEDICINE;

DIAGNOSTICS; NANOMEDICINE; NANOPARTICLES; THERAPEUTICS;

NANOTECHNOLOGY;

AMPHOTERICIN B LIPID COMPLEX; ATRIDOX; CARMUSTINE; DAUNORUBICIN; DEPOTDUR; DOXORUBICIN; GOSERELIN; LEUPRORELIN; LIPOSOME; MORPHINE; OCTREOTIDE; PACLITAXEL; POLYMER; TRIPTORELIN; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

ARTICLE; BREAST CANCER; CONTROLLED DRUG RELEASE; DIAGNOSTIC IMAGING; DRUG DELIVERY SYSTEM; GENE VECTOR; HUMAN; KAPOSI SARCOMA; LYMPH NODE METASTASIS; MICELLE; NANOPARTICLE; NANOTECHNOLOGY; NONHUMAN; PRIORITY JOURNAL; QUANTUM DOT; RNA INTERFERENCE; VIRUS PARTICLE;

EID: 33751419875     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2006.09.011     Document Type: Note

References (20)

1. Bangham A.D., Standish M.M., and Watkins J.C. Diffusion of univalent ions across the lamellae of swollen phospholipids. J. Mol. Biol. 13 (1965) 238-252
2. Langer R., and Folkman J. Polymers for the sustained release of proteins and other macromolecules. Nature 263 (1976) 797-800
3. Gref R., Minamitake Y., Peracchia M.T., Trubetskoy V., Torchilin V., and Langer R. Biodegradable long-circulating polymeric nanospheres. Science 263 (1994) 1600-1603
4. Bruchez Jr. M., Moronne M., Gin P., Weiss S., and Alivisatos A.P. Semiconductor nanocrystals as fluorescent biological labels. Science 281 (1998) 2013-2016
5. Chan W.C., and Nie S. Quantum dot bioconjugates for ultrasensitive nonisotopic detection. Science 281 (1998) 2016-2018
6. Cui Y., Wei Q., Park H., and Lieber C.M. Nanowire nanosensors for highly sensitive and selective detection of biological and chemical species. Science 293 (2001) 1289-1292
7. Ferrari M. Cancer nanotechnology: opportunities and challenges. Nat. Rev., Cancer 5 (2005) 161-171
8. Langer R. Drug delivery and targeting. Nature 392 (1998) 5-10
9. Brannon-Peppas L., and Blanchette J.O. Nanoparticle and targeted systems for cancer therapy. Adv. Drug Deliv. Rev. 56 (2004) 1649-1659
10. van Vlerken L.E., and Amiji M.M. Multi-functional polymeric nanoparticles for tumour-targeted drug delivery. Expert Opin. Drug Deliv. 3 (2006) 205-216
11. Farokhzad O.C., Karp K.J., and Langer R. Nanoparticle-aptamer bioconjugates for cancer targeting. Expert Opin. Drug Deliv. 3 (2006) 311-324
12. Farokhzad O.C., Cheng J., Teply B.A., Sherifi I., Jon S., Kantoff P.W., Richie J.P., and Langer R. Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 6315-6320
13. Sengupta S., Eavarone D., Capila I., Zhao G., Watson N., Kiziltepe T., and Sasisekharan R. Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system. Nature 436 (2005) 568-572
14. Harries M., Ellis P., and Harper P. Nanoparticle albumin-bound paclitaxel for metastatic breast cancer. J. Clin. Oncol. 23 (2005) 7768-7771
15. Harisinghani M.G., Barentsz J., Hahn P.F., Deserno W.M., Tabatabaei S., van de Kaa C.H., de la Rosette J., and Weissleder R. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N. Engl. J. Med. 348 (2003) 2491-2499
16. Kim S., Lim Y.T., Soltesz E.G., De Grand A.M., Lee J., Nakayama A., Parker J.A., Mihaljevic T., Laurence R.G., and Dor D.M. Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping. Nat. Biotechnol. 22 (2004) 93-97
17. Loo C., Lowery A., Halas N., West J., and Drezek R. Immunotargeted nanoshells for integrated cancer imaging and therapy. Nano Lett. 5 (2005) 709-711
18. Anderson D.G., Peng W., Akinc A., Hossain N., Kohn A., Padera R., Langer R., and Sawicki J.A. A polymer library approach to suicide gene therapy for cancer. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 16028-16033
19. Maeda H. The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv. Enzyme Regul. 41 (2001) 89-207
20. Jain R.K. Vascular and interstitial barriers to delivery of therapeutic agents in tumors. Cancer Metastasis Rev. 9 (1990) 253-266